Vemurafenib-induced neutrophilic panniculitis in a child with a brainstem glioma.
Pediatr Dermatol
; 32(1): 153-4, 2015.
Article
en En
| MEDLINE
| ID: mdl-24602192
ABSTRACT
Neutrophilic panniculitis is a rare adverse effect of therapy with selective BRAF inhibitors. We report a case of neutrophilic panniculitis in a 15-year-old girl receiving treatment with vemurafenib for a brainstem glioma. Clinicians should be aware of this rare but important side effect of vemurafenib. This is the first report of neutrophilic panniculitis in a child treated with vemurafenib.
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Sulfonamidas
/
Paniculitis
/
Proteínas Proto-Oncogénicas B-raf
/
Indoles
/
Neutrófilos
/
Antineoplásicos
Límite:
Adolescent
/
Female
/
Humans
Idioma:
En
Revista:
Pediatr Dermatol
Año:
2015
Tipo del documento:
Article